Companies / Dogwood Therapeutics, Inc. / Activity
Activity — Dogwood Therapeutics, Inc.
4 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Duncan Gregory Scott CEO | Grant | Stock Option (right to buy) | — | +330K | 330,000 0.98% of shares | low |
| Mar 5, 2026 | Gendreau Roger Michael Executive | Grant | Stock Option (right to buy) | — | +83K | 82,500 0.25% of shares | low |
| Mar 5, 2026 | Grosswald Ralph Executive | Grant | Stock Option (right to buy) | — | +83K | 82,500 0.25% of shares | low |
| Mar 5, 2026 | Walsh Angela Executive | Grant | Stock Option (right to buy) | — | +83K | 82,500 0.25% of shares | low |